Surgery Partners, Inc. (NASDAQ:SGRY) Receives Consensus Rating of “Moderate Buy” from Analysts

Surgery Partners, Inc. (NASDAQ:SGRY) has earned an average rating of “Moderate Buy” from the ten brokerages that are currently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and seven have assigned a buy recommendation to the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $27.1111.

SGRY has been the subject of a number of analyst reports. Barclays reduced their price objective on shares of Surgery Partners from $24.00 to $18.00 and set an “equal weight” rating for the company in a report on Friday, November 21st. Royal Bank Of Canada decreased their price objective on Surgery Partners from $35.00 to $31.00 and set an “outperform” rating for the company in a report on Tuesday, November 11th. Weiss Ratings restated a “sell (e+)” rating on shares of Surgery Partners in a report on Monday, December 29th. JPMorgan Chase & Co. cut their target price on Surgery Partners from $27.00 to $20.00 and set a “neutral” rating on the stock in a research report on Monday, November 24th. Finally, UBS Group lowered their price target on Surgery Partners from $34.00 to $29.00 and set a “buy” rating for the company in a research report on Thursday, November 13th.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the company. Pentwater Capital Management LP grew its position in Surgery Partners by 66.9% in the 3rd quarter. Pentwater Capital Management LP now owns 11,681,000 shares of the company’s stock worth $252,777,000 after purchasing an additional 4,681,000 shares in the last quarter. UBS Group AG boosted its stake in shares of Surgery Partners by 111.4% in the 4th quarter. UBS Group AG now owns 7,803,974 shares of the company’s stock worth $120,571,000 after buying an additional 4,113,052 shares during the last quarter. Vanguard Group Inc. grew its holdings in shares of Surgery Partners by 5.9% in the third quarter. Vanguard Group Inc. now owns 7,614,514 shares of the company’s stock valued at $164,778,000 after acquiring an additional 424,518 shares in the last quarter. King Street Capital Management L.P. grew its holdings in shares of Surgery Partners by 24.5% in the second quarter. King Street Capital Management L.P. now owns 6,225,000 shares of the company’s stock valued at $138,382,000 after acquiring an additional 1,225,000 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its position in shares of Surgery Partners by 25.5% during the third quarter. Dimensional Fund Advisors LP now owns 4,860,215 shares of the company’s stock valued at $105,177,000 after acquiring an additional 988,956 shares during the last quarter.

Surgery Partners Price Performance

Shares of NASDAQ:SGRY opened at $15.00 on Thursday. Surgery Partners has a twelve month low of $13.14 and a twelve month high of $26.16. The stock’s 50 day moving average is $15.53 and its 200-day moving average is $19.00. The company has a quick ratio of 1.72, a current ratio of 1.88 and a debt-to-equity ratio of 1.10. The firm has a market capitalization of $1.94 billion, a price-to-earnings ratio of -11.03 and a beta of 1.97.

Surgery Partners (NASDAQ:SGRY) last announced its quarterly earnings results on Monday, November 10th. The company reported $0.13 EPS for the quarter, missing analysts’ consensus estimates of $0.19 by ($0.06). Surgery Partners had a negative net margin of 5.21% and a positive return on equity of 2.41%. The business had revenue of $821.50 million for the quarter, compared to the consensus estimate of $823.55 million. During the same quarter last year, the firm posted $0.19 EPS. The business’s revenue for the quarter was up 6.6% compared to the same quarter last year. Sell-side analysts forecast that Surgery Partners will post 0.67 EPS for the current fiscal year.

Surgery Partners Company Profile

Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.